Adagio Financial Statements From 2010 to 2025

ADGM Stock   1.04  0.02  1.89%   
Adagio Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Adagio Medical's valuation are provided below:
Gross Profit
-2 M
Market Capitalization
22.5 M
Enterprise Value Revenue
370.2497
Revenue
137 K
Earnings Share
(2.41)
There are over one hundred nineteen available fundamental signals for Adagio Medical Holdings,, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to validate Adagio Medical's prevailing fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road.

Adagio Medical Total Revenue

282,700

Check Adagio Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adagio Medical's main balance sheet or income statement drivers, such as Other Operating Expenses of 65.9 M, Total Operating Expenses of 63.9 M or Interest Income of 2.6 K, as well as many indicators such as Price To Sales Ratio of 56.36, Dividend Yield of 0.0 or PTB Ratio of 0.84. Adagio financial statements analysis is a perfect complement when working with Adagio Medical Valuation or Volatility modules.
  
Build AI portfolio with Adagio Stock
Check out the analysis of Adagio Medical Correlation against competitors.

Adagio Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets50.9 M48.4 M8.5 M
Slightly volatile
Short and Long Term Debt Total17.7 M16.3 M5.8 M
Slightly volatile
Other Current Liabilities3.1 M4.8 M1.1 M
Slightly volatile
Total Current Liabilities15.5 M7.8 M5.4 M
Slightly volatile
Accounts Payable1.8 M2.8 M647.3 K
Slightly volatile
Non Current Assets Total24.3 M23.1 M3.3 M
Slightly volatile
Non Currrent Assets Other20.1 K14 K34.6 K
Slightly volatile
Common Stock Shares Outstanding12.9 M15.2 M17.8 M
Slightly volatile
Liabilities And Stockholders Equity50.9 M48.4 M8.5 M
Slightly volatile
Other Current Assets2.3 M2.2 M386.4 K
Slightly volatile
Total Liabilities27.1 M28.5 M24.6 M
Slightly volatile
Total Current Assets26.6 M25.3 M5.2 M
Slightly volatile
Short Term Debt135.8 K143 K3.6 M
Slightly volatile
Property Plant And Equipment NetM2.1 M1.8 M
Slightly volatile
Cash12.8 M20.6 M16.7 M
Slightly volatile
Cash And Short Term Investments12.8 M20.6 M16.7 M
Slightly volatile
Non Current Liabilities Total19.7 M20.8 M82.6 M
Slightly volatile
Inventory1.8 M2.6 M754.7 K
Slightly volatile
Other Stockholder Equity95 M90.5 M12.3 M
Slightly volatile
Property Plant And Equipment Gross3.8 M4.9 M2.8 M
Slightly volatile
Accumulated Other Comprehensive Income95010005.9 K
Slightly volatile
Capital Stock1.4 KK1.1 K
Slightly volatile
Non Current Liabilities Other3.8 M3.6 M467.7 K
Slightly volatile
Common Stock1.4 KK1.1 K
Slightly volatile
Short and Long Term Debt27 M45.6 M14.7 M
Slightly volatile
Long Term Debt8.9 M16.1 M1.7 M
Slightly volatile
Short Term Investments1.1 M1.2 M1.3 M
Slightly volatile
Intangible Assets5.6 M6.3 M6.8 M
Slightly volatile

Adagio Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses65.9 M62.7 M12.6 M
Slightly volatile
Total Operating Expenses63.9 M60.8 M12.2 M
Slightly volatile
Interest Income2.6 K2.7 K5.2 K
Pretty Stable
Selling General Administrative3.3 M4.3 M5.8 M
Slightly volatile
Total Revenue282.7 K269 K267.5 K
Very volatile
Research Development4.4 M4.6 M14.2 M
Slightly volatile
Cost Of Revenue1.5 M1.9 M1.2 M
Slightly volatile
Reconciled Depreciation499.8 K611.8 K385.7 K
Slightly volatile
Selling And Marketing Expenses5.4 M6.1 M6.7 M
Slightly volatile

Adagio Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation491.7 K642 K375.5 K
Slightly volatile
Begin Period Cash Flow19.2 K20.2 K29.8 M
Slightly volatile
Other Cashflows From Financing Activities16.4 M15.6 M2.7 M
Slightly volatile
Depreciation760.4 K1.4 M451.3 K
Slightly volatile
Capital ExpendituresM1.6 M1.2 M
Slightly volatile
Total Cash From Financing Activities13 M15.6 M3.8 M
Slightly volatile
End Period Cash Flow12.8 M20.6 M16.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio56.3659.324562
Slightly volatile
Days Sales Outstanding47.647.490750.1994
Slightly volatile
Stock Based Compensation To Revenue1.412.38661.3917
Slightly volatile
Capex To Depreciation0.540.56973.012
Slightly volatile
EV To Sales41.143.2608568
Slightly volatile
Inventory Turnover0.720.75492.8661
Slightly volatile
Days Of Inventory On Hand334484198
Slightly volatile
Payables Turnover1.070.6821.6875
Slightly volatile
Sales General And Administrative To Revenue16.7518.2221.8822
Slightly volatile
Research And Ddevelopement To Revenue16.3717.226853.8651
Slightly volatile
Capex To Revenue2.721.3684.0257
Slightly volatile
Cash Per Share1.421.35450.2221
Slightly volatile
Days Payables Outstanding442535291
Slightly volatile
Intangibles To Total Assets0.340.390.4237
Slightly volatile
Current Ratio3.433.26540.4881
Slightly volatile
Receivables Turnover7.377.68577.6055
Slightly volatile
Capex Per Share0.0440.02420.0583
Slightly volatile
Revenue Per Share0.0160.01770.0157
Slightly volatile
Interest Debt Per Share1.360.99770.5436
Slightly volatile
Debt To Assets0.320.33570.7293
Slightly volatile
Operating Cycle370531242
Slightly volatile
Days Of Payables Outstanding442535291
Slightly volatile
Quick Ratio3.082.93480.4361
Slightly volatile
Cash Ratio2.782.65180.4308
Slightly volatile
Days Of Inventory Outstanding334484198
Slightly volatile
Days Of Sales Outstanding47.647.490750.1994
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.841.0230.3979
Slightly volatile
Fixed Asset Turnover0.150.12520.1541
Slightly volatile
Debt Ratio0.320.33570.7293
Slightly volatile
Price Sales Ratio56.3659.324562
Slightly volatile
Asset Turnover0.00530.00560.0061
Slightly volatile

Adagio Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap15.2 M16 M64.2 M
Slightly volatile
Enterprise Value11.1 M11.6 M97.4 M
Slightly volatile

Adagio Fundamental Market Drivers

About Adagio Medical Financial Statements

Adagio Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Adagio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-1 M-1.1 M
Total Revenue269 K282.7 K
Cost Of Revenue1.9 M1.5 M
Stock Based Compensation To Revenue 2.39  1.41 
Sales General And Administrative To Revenue 18.22  16.75 
Research And Ddevelopement To Revenue 17.23  16.37 
Capex To Revenue 1.37  2.72 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(232.27)(220.65)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Adagio Medical Holdings, is a strong investment it is important to analyze Adagio Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagio Medical's future performance. For an informed investment choice regarding Adagio Stock, refer to the following important reports:
Check out the analysis of Adagio Medical Correlation against competitors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagio Medical. If investors know Adagio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagio Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.41)
Revenue Per Share
0.009
Quarterly Revenue Growth
0.756
Return On Assets
(0.24)
Return On Equity
(2.10)
The market value of Adagio Medical Holdings, is measured differently than its book value, which is the value of Adagio that is recorded on the company's balance sheet. Investors also form their own opinion of Adagio Medical's value that differs from its market value or its book value, called intrinsic value, which is Adagio Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagio Medical's market value can be influenced by many factors that don't directly affect Adagio Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagio Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagio Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagio Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.